SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001354488-10-000658
Filing Date
2010-03-05
Accepted
2010-03-05 16:25:38
Documents
5
Period of Report
2010-03-03
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ltus_8k.htm 8-K 34306
2 STANDBY EQUITY DISTRIBUTION AGREEMENT, DATED AS OF MARCH 3, 2010, BY AND BETWEEN ltus_ex101.htm EX-10.1 333949
3 PRESS RELEASE ISSUED BY LOTUS PHARMACEUTICALS, INC. ON MARCH 3, 2010 ltus_ex991.htm EX-99.1 22039
4 img001.jpg GRAPHIC 6014
5 img002.jpg GRAPHIC 6444
  Complete submission text file 0001354488-10-000658.txt   409393
Mailing Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071
Business Address 16 CHENG ZHUANG ROAD FENG TAI DISTRICT BEIJING F4 100071 86-10-63899868
Lotus Pharmaceuticals, Inc. (Filer) CIK: 0001292087 (see all company filings)

IRS No.: 200507918 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32581 | Film No.: 10661055
SIC: 2834 Pharmaceutical Preparations